Krystal Biotech, Inc. (BIT:1KRYS)

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	308.77	344.87	358.33	161.9	341.25	268.27
Short-Term Investments	308.08	252.65	173.85	217.27	96.85	2.99
Cash & Short-Term Investments	616.85	597.52	532.18	379.17	438.1	271.26
Cash Growth	14.60%	12.28%	40.35%	-13.45%	61.50%	40.05%
Receivables	103.26	104.75	42.04	-	-	-
Inventory	29.94	26.51	6.99	-	-	-
Prepaid Expenses	16.75	13.27	6.71	4.61	4.17	3.8
Total Current Assets	766.8	742.05	587.91	383.78	442.27	275.06
Property, Plant & Equipment	158.93	161.45	168.23	169.73	119.58	34.17
Long-Term Investments	148.47	152.11	61.95	4.62	64.37	-
Other Long-Term Assets	0.22	0.23	0.26	0.32	0.07	1.61
Total Assets	1,074	1,056	818.36	558.45	626.3	310.84
Accounts Payable	2.67	4.99	4.13	3.98	8.4	2.11
Accrued Expenses	59.29	52.78	18.15	11.54	6.52	3.99
Current Portion of Leases	1.36	1.22	1.47	1.56	1.04	0.64
Current Income Taxes Payable	11.43	4.29	1.96	0.04	0.08	0.04
Other Current Liabilities	4.73	38.73	7.38	11.72	9.69	8.68
Total Current Liabilities	79.49	102	33.09	28.85	25.74	15.45
Long-Term Leases	8.3	6.04	6.62	7.37	6.98	3.31
Other Long-Term Liabilities	1.95	1.42	-	-	-	-
Total Liabilities	89.74	109.46	39.71	36.22	32.72	18.76
Additional Paid-In Capital	1,129	1,127	1,048	803.72	734.52	363.29
Retained Earnings	-144.94	-180.67	-269.83	-280.76	-140.78	-71.21
Comprehensive Income & Other	0.39	-0.19	0.64	-0.73	-0.16	0.01
Total Common Equity	984.67	946.38	778.64	522.23	593.58	292.08
Shareholders' Equity	984.67	946.38	778.64	522.23	593.58	292.08
Total Liabilities & Equity	1,074	1,056	818.36	558.45	626.3	310.84
Total Debt	9.66	7.26	8.09	8.93	8.02	3.95
Net Cash (Debt)	755.66	742.37	586.04	374.86	494.44	267.32
Net Cash Growth	23.00%	26.68%	56.34%	-24.19%	84.97%	40.38%
Net Cash Per Share	25.29	24.96	21.12	14.70	22.28	14.23
Filing Date Shares Outstanding	28.9	28.81	28.29	25.76	25.21	22.19
Total Common Shares Outstanding	28.9	28.79	28.24	25.76	25.21	19.71
Working Capital	687.31	640.05	554.82	354.93	416.53	259.61
Book Value Per Share	34.07	32.87	27.58	20.27	23.55	14.82
Tangible Book Value	984.67	946.38	778.64	522.23	593.58	292.08
Tangible Book Value Per Share	34.07	32.87	27.58	20.27	23.55	14.82
Buildings	109.14	111.44	111.18	-	-	-
Machinery	35.64	34.19	30.49	12.93	6.51	5.58
Construction In Progress	4.87	5.78	7.29	131.33	104.34	23.03
Leasehold Improvements	25.69	25.67	25.07	24.22	5.72	4.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.